Free radical damage and antioxidant stress are implicated as key mechanisms underlying ALS, with one of the first mutations identified associated with familial ALS being mutations in the SOD1 gene [71] with a recent licenced drug being a free-radical scavenger (edaravone). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.